Growth hormone doesn’t produce a single dramatic change on a fixed schedule. Different effects unfold over different timelines, from weeks to well over a year, depending on what you’re measuring. The earliest subjective improvements can appear within the first few months, while changes to bone density take 18 months or longer to show up.
Here’s what the research shows for each major effect, broken down by timeline.
Height Growth in Children: 3 to 6 Months
For children prescribed growth hormone for short stature or growth hormone deficiency, the response is relatively fast. In a study of prepubertal children, growth velocity nearly tripled by week 13, jumping from about 4.5 cm per year at baseline to nearly 11.7 cm per year. By 26 weeks (6 months), growth velocity remained elevated at about 10.9 cm per year, representing a sustained increase of over 6 cm per year compared to before treatment.
Measurable gains in height showed up as early as 13 weeks, with statistically significant improvements continuing through the 6-month mark. Parents and pediatricians typically evaluate the first-year response to decide whether treatment is working well enough to continue. The strongest growth acceleration tends to happen in that first year, then gradually tapers in subsequent years while still outpacing untreated growth rates.
Body Fat Reduction: 4 to 8 Months
Growth hormone has a well-documented effect on body composition, particularly trunk fat, the fat stored around your midsection. In the clinical trial the FDA used to approve a weekly growth hormone therapy, patients with adult growth hormone deficiency saw a 1.06% average decrease in trunk fat over 34 weeks (about 8 months). The placebo group actually gained trunk fat during the same period, increasing by 0.47%. That net difference of roughly 1.5 percentage points may sound modest, but trunk fat is specifically the type linked to cardiovascular and metabolic risk.
Most people won’t notice visible fat loss in a mirror within the first month or two. The metabolic shift happens gradually, and measurable changes in body composition generally require at least 3 to 4 months of consistent therapy.
Muscle Strength: 6 Months or More
Growth hormone’s relationship with muscle is more nuanced than many people expect. It strongly stimulates collagen production in tendons and muscle tissue, which reinforces the structural framework around muscles. But it doesn’t appear to directly boost the contractile muscle fibers themselves in the way testosterone or resistance training does.
In a study of men over 50, six months of growth hormone therapy produced a statistically significant increase in leg press strength. Upper body strength (bench press) did not improve in either the treatment or placebo group over the same period. This pattern suggests growth hormone works best as a support for connective tissue and lower-body function rather than as a broad muscle-building agent. If strength gains are your primary goal, growth hormone alone is unlikely to deliver dramatic results in under six months, and its effects will be selective rather than uniform across all muscle groups.
Energy and Quality of Life: 2 to 4 Months
Improvements in how you feel day to day are among the earlier benefits people report. In a controlled trial of adults with growth hormone deficiency, quality-of-life scores improved significantly after four months of treatment compared to placebo. Patients reported fewer of the complaints common to growth hormone deficiency: fatigue, low motivation, and reduced vitality.
Sleep quality is a common concern for people starting therapy. While the same study found a trend toward better subjective sleep scores, the difference didn’t reach statistical significance at four months. So you may feel generally better and more energetic within a few months, but dramatic sleep improvements aren’t guaranteed by the therapy alone.
Cognitive Function: 10 to 20 Weeks
Growth hormone influences the brain partly through IGF-1, a secondary hormone the liver produces in response to growth hormone. In a 20-week trial of older adults, including those with mild cognitive impairment, boosting growth hormone signaling improved executive function (planning, decision-making, mental flexibility) with a moderate-to-large effect size. Benefits were detectable at both the 10-week and 20-week checkpoints, with no additional acceleration between those two points. That suggests the cognitive benefit kicks in within the first couple of months and then holds steady.
Verbal memory showed a trend toward improvement but didn’t reach strong statistical significance. Visual memory was unaffected, and mood and sleep quality did not change. So the cognitive benefits are real but specific: sharper executive thinking rather than a broad mental upgrade.
Cholesterol and Heart Health: About 12 Months
Growth hormone deficiency is associated with unfavorable cholesterol profiles and thicker artery walls. After 12 months of therapy, studies have documented significant reductions in total cholesterol, triglycerides, and LDL (“bad”) cholesterol, along with increases in HDL (“good”) cholesterol. Carotid artery wall thickness, a marker of cardiovascular risk, also decreased significantly at the one-year mark. These aren’t changes you’ll feel, but they show up clearly on blood work and imaging, and they matter for long-term health.
Bone Density: 18 Months Minimum
Bone density follows a counterintuitive pattern that catches many patients off guard. In the first six months of growth hormone therapy, bone density actually decreases. At the lumbar spine, it dropped by about 0.89% at month six. At the hip, it dropped by 0.62%. This happens because growth hormone activates bone remodeling, and the body breaks down old bone before laying down new bone. It’s a normal part of the process, not a sign that treatment is failing.
By 12 months, bone density climbs back toward baseline but typically hasn’t surpassed it yet. Only after 18 months did lumbar spine density rise significantly above where it started, increasing by about 1.4%. Hip density still hadn’t changed meaningfully even at 18 months. Researchers note that you generally need 18 to 24 months of continuous therapy before bone density gains become apparent. This is one of the longest timelines in growth hormone treatment, and it requires patience and consistent follow-up imaging to track properly.
IGF-1 Levels: Days to One Week
The fastest measurable response to growth hormone is the rise in IGF-1, the downstream hormone your liver produces when growth hormone signals it to. With weekly formulations, IGF-1 levels reach a predictable steady state after just one dosing interval, meaning within about a week of your first injection. Peak IGF-1 levels occur around day 2 after a dose, and average levels are best captured around day 4.
Your doctor will likely check IGF-1 levels early in treatment to confirm your dose is appropriate. Reaching the right IGF-1 range quickly is important because it’s the foundation for all the downstream effects on fat, muscle, bone, and cognition described above.
Common Side Effects and When They Appear
The most frequently reported side effects are joint pain, muscle aches, and fluid retention (swelling in the hands, feet, or ankles). These tend to appear early in treatment, often within the first weeks, and are generally transient. They’re related to the sudden shift in fluid balance and tissue growth that growth hormone triggers. In many cases, a temporary dose reduction resolves them. If you notice your rings feeling tight or your ankles puffing up shortly after starting therapy, that’s a well-known early response rather than something unusual.
In children, side effects are often attributed to the accelerated growth the body undergoes. For adults, the fluid-related symptoms are more common at higher doses and in older patients. Most side effects ease as the body adjusts over the first few months.